Warning over prescription drugs causing impulsive behaviour | BBC News

Key Concepts

• Dopamine Agonists: Medications that increase dopamine activity in the brain, used to treat conditions like Parkinson’s disease and Tourette’s syndrome.
• Impulse Control Disorder (ICD): A condition characterized by an inability to resist urges or impulses, leading to harmful or risky behaviors. Specifically, the report focuses on hypersexuality, compulsive gambling, and erratic spending.
• MHRA (Medicines and Healthcare products Regulatory Agency): The UK’s drug regulator responsible for ensuring the safety and efficacy of medicines.
• Parkinson’s Disease: A progressive neurological disorder that affects movement.
• Tourette’s Syndrome: A neurological disorder characterized by repetitive, stereotyped movements or vocalizations called tics.
• Arapitra: A specific dopamine agonist used to treat Tourette’s Syndrome.

Investigation into Impulse Control Disorders Linked to Medications

This investigation, conducted by BBC News correspondent Nell Tiidge, reveals a concerning link between certain medications – specifically dopamine agonists – and the development of severe impulse control disorders in patients. The report highlights the devastating consequences for individuals and their families, and raises questions about the adequacy of warnings and regulatory oversight.

The Case of Bill & Freddy

The investigation centers on the tragic case of Bill, a retired teacher prescribed dopamine agonists for Parkinson’s disease. Prior to medication, Bill was described as “incredibly straightlaced” and risk-averse. Following the commencement of treatment, his behavior drastically changed. He began openly watching pornography, driving erratically, and ultimately sold the family home, falling victim to a romance scam in Ghana. He lost approximately £300,000. His son, Freddy, was never warned about these potential side effects. Bill’s death three years ago continues to impact Freddy profoundly, who describes the situation as a “massive scandal.” As Freddy stated, “Don’t worry, Freddy. Take a moment,” highlighting the emotional toll of the situation.

Widespread Impact & Similar Cases

Freddy’s experience is not isolated. The investigation uncovered numerous similar cases where patients experienced compulsive gambling, hypersexuality, and reckless spending after starting dopamine agonists.

• One man stole £600,000 to fund his impulsive behaviors, ultimately leading to suicide.
• A woman lost over £150,000 to gambling.
• Brandon, diagnosed with Tourette’s syndrome, began gambling at age 11 after being prescribed Arapitra. He accumulated over £100,000 in debt, stole from family, and borrowed from numerous individuals, stating, “It’s ruined my life.” He also reported a lack of warning about potential side effects.

Regulatory Response & Concerns

The UK’s drug regulator, the MHRA, currently has no plans to strengthen warnings regarding these side effects. They justify this by stating that many patients do not report these issues, making it difficult to accurately assess the frequency. This decision is criticized as inadequate, as the side effects significantly impact not only individuals but also their families and communities. The chair of the UK Health Select Committee expressed dismay at the “systems” failing these families and emphasized the need for patients to have access to information enabling them to “mitigate” the risks.

How Dopamine Agonists Contribute to ICDs

Dopamine agonists work by increasing dopamine levels in the brain. While beneficial for conditions like Parkinson’s disease (where dopamine production is reduced, leading to tremors and shakes), the increased dopamine activity can also overstimulate the brain’s reward system. This overstimulation is believed to be a key factor in the development of impulsive behaviors. As explained in the broadcast, dopamine is “key in driving feelings of reward and enjoyment.”

Manufacturer & NHS Response

Drug manufacturers maintain that their products have undergone extensive trials and are repeatedly approved by regulators worldwide, with side effects clearly stated. The NHS advises patients with concerns to consult their doctor. The drugs are widely prescribed, with over 1.5 million prescriptions issued by GPs in England alone last year.

Data & Statistics

• Approximately one in six Parkinson’s patients are affected by these impulse control side effects.
• Over 1.5 million prescriptions for dopamine agonists were issued by GPs in England last year.
• Brandon lost over £100,000 to gambling.
• One man stole £600,000 to fund impulsive behaviors.
• A woman lost over £150,000 to gambling.
• Bill lost approximately £300,000 to a romance scam.

Current Actions & Future Steps

Following the investigation, the chair of the UK Health Select Committee has written to the MHRA, requesting a review of their findings and advocating for the inclusion of impulse control disorder frequency in medication warnings.

Synthesis/Conclusion

This investigation reveals a significant and under-recognized risk associated with dopamine agonist medications. The lack of adequate warnings and the MHRA’s reluctance to strengthen regulations are leaving vulnerable patients and their families exposed to devastating consequences. The cases highlighted demonstrate the urgent need for increased awareness, improved communication between doctors and patients, and a re-evaluation of the current regulatory approach to ensure patient safety and well-being. The investigation underscores the importance of recognizing the potential for these side effects and proactively addressing them to prevent further harm.